Adalimumab clinical efficacy is associated with rheumatoid factor and anti-cyclic citrullinated peptide antibody titer reduction: a one-year prospective study.

Atzeni F, Sarzi-Puttini P, Dell' Acqua D, de Portu S, Cecchini G, Cruini C, Carrabba M, Meroni PL.

Arthritis Res Ther. 2006;8(1):R3.

PMID: 16356192 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

[Correlation between different clinical activity and anti CC-P (anti-cyclic citrullinated peptide antibodies) titres in rheumatoid arthritis treated with three different tumor necrosis factors TNF-alpha blockers]

Benucci M, Turchini S, Parrochi P, Boccaccini P, Manetti R, Cammelli E, Manfredi M.

Recenti Prog Med. 2006 Mar;97(3):134-9. Italian.

PMID: 16700418 [PubMed - indexed for MEDLINE]

Related Articles

High IgA rheumatoid factor levels are associated with poor clinical response to tumour necrosis factor alpha inhibitors in rheumatoid arthritis.

Bobbio-Pallavicini F, Caporali R, Alpini C, Avalle S, Epis OM, Klersy C, Montecucco C.

Ann Rheum Dis. 2007 Mar;66(3):302-7. Epub 2006 Nov 1.

PMID: 17079248 [PubMed - indexed for MEDLINE]

Related Articles

Decrease of anti-cyclic citrullinated peptide antibodies and rheumatoid factor following anti-TNFalpha therapy (infliximab) in rheumatoid arthritis is associated with clinical improvement.

Alessandri C, Bombardieri M, Papa N, Cinquini M, Magrini L, Tincani A, Valesini G.

Ann Rheum Dis. 2004 Oct;63(10):1218-21.

PMID: 15361374 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

Rheumatoid factor, but not anti-cyclic citrullinated peptide antibodies, is modulated by infliximab treatment in rheumatoid arthritis.

De Rycke L, Verhelst X, Kruithof E, Van den Bosch F, Hoffman IE, Veys EM, De Keyser F.

Ann Rheum Dis. 2005 Feb;64(2):299-302. Epub 2004 May 27.

PMID: 15166003 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

Impact of three anti-TNFalpha biologics on existing and emergent autoimmunity in rheumatoid arthritis and spondylarthropathy patients.

Bacquet-Deschryver H, Jouen F, Quillard M, Ménard JF, Goëb V, Lequerré T, Mejjad O, Daragon A, Tron F, Le Loët X, Vittecoq O.

J Clin Immunol. 2008 Sep;28(5):445-55. Epub 2008 Jun 28.

PMID: 18587633 [PubMed - indexed for MEDLINE]

Related Articles

Antibodies against cyclic citrullinated peptides in patients affected by rheumatoid arthritis before and after infliximab treatment.

Caramaschi P, Biasi D, Tonolli E, Pieropan S, Martinelli N, Carletto A, Volpe A, Bambara LM.

Rheumatol Int. 2005 Nov;26(1):58-62. Epub 2005 Feb 23.

PMID: 15726373 [PubMed - indexed for MEDLINE]

Related Articles

Organ-specific autoantibodies in patients with rheumatoid arthritis treated with adalimumab: a prospective long-term follow-up.

Atzeni F, Doria A, Ghirardello A, Villalta D, Zampieri S, Carrabba M, Sarzi-Puttini P.

Autoimmunity. 2008 Feb;41(1):87-91.

PMID: 18176869 [PubMed - indexed for MEDLINE]

Related Articles

Anti-nucleosome antibodies as prediction factor of development of autoantibodies during therapy with three different TNFalpha blocking agents in rheumatoid arthritis.

Benucci M, Saviola G, Baiardi P, Cammelli E, Manfredi M.

Clin Rheumatol. 2008 Jan;27(1):91-5. Epub 2007 Oct 10.

PMID: 17929076 [PubMed - indexed for MEDLINE]

Related Articles

Infliximab therapy in rheumatoid arthritis and ankylosing spondylitis-induced specific antinuclear and antiphospholipid autoantibodies without autoimmune clinical manifestations: a two-year prospective study.

Ferraro-Peyret C, Coury F, Tebib JG, Bienvenu J, Fabien N.

Arthritis Res Ther. 2004;6(6):R535-43. Epub 2004 Sep 23.

PMID: 15535831 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

The effect of etanercept on anti-cyclic citrullinated peptide antibodies and rheumatoid factor in patients with rheumatoid arthritis.

Chen HA, Lin KC, Chen CH, Liao HT, Wang HP, Chang HN, Tsai CY, Chou CT.

Ann Rheum Dis. 2006 Jan;65(1):35-9. Epub 2005 Jun 23.

PMID: 15975966 [PubMed - indexed for MEDLINE]

Related Articles

Autoimmunity and anti-TNF-alpha agents.

Atzeni F, Turiel M, Capsoni F, Doria A, Meroni P, Sarzi-Puttini P.

Ann N Y Acad Sci. 2005 Jun;1051:559-69. Review.

PMID: 16126996 [PubMed - indexed for MEDLINE]

Related Articles

Autoantibody profile in rheumatoid arthritis during long-term infliximab treatment.

Bobbio-Pallavicini F, Alpini C, Caporali R, Avalle S, Bugatti S, Montecucco C.

Arthritis Res Ther. 2004;6(3):R264-72. Epub 2004 Apr 26.

PMID: 15142273 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

Impact of treatment with infliximab on anticyclic citrullinated peptide antibody and rheumatoid factor in patients with rheumatoid arthritis.

Ahmed MM, Mubashir E, Wolf RE, Hayat S, Hall V, Shi R, Berney SM.

South Med J. 2006 Nov;99(11):1209-15.

PMID: 17195414 [PubMed - indexed for MEDLINE]

Related Articles

Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials.

Charles PJ, Smeenk RJ, De Jong J, Feldmann M, Maini RN.

Arthritis Rheum. 2000 Nov;43(11):2383-90.

PMID: 11083258 [PubMed - indexed for MEDLINE]

Related Articles

Autoantibody formation in patients with rheumatoid arthritis treated with anti-TNF alpha.

Eriksson C, Engstrand S, Sundqvist KG, Rantapää-Dahlqvist S.

Ann Rheum Dis. 2005 Mar;64(3):403-7. Epub 2004 Aug 5.

PMID: 15297281 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

Induction of autoantibodies in refractory rheumatoid arthritis treated by infliximab.

Allanore Y, Sellam J, Batteux F, Job Deslandre C, Weill B, Kahan A.

Clin Exp Rheumatol. 2004 Nov-Dec;22(6):756-8.

PMID: 15638051 [PubMed - indexed for MEDLINE]

Related Articles

Infliximab, but not etanercept, induces IgM anti-double-stranded DNA autoantibodies as main antinuclear reactivity: biologic and clinical implications in autoimmune arthritis.

De Rycke L, Baeten D, Kruithof E, Van den Bosch F, Veys EM, De Keyser F.

Arthritis Rheum. 2005 Jul;52(7):2192-201.

PMID: 15986349 [PubMed - indexed for MEDLINE]

Related Articles

IgM-rheumatoid factor, anti-cyclic citrullinated peptide, and anti-citrullinated human fibrinogen antibodies decrease during treatment with the tumor necrosis factor blocker infliximab in patients with rheumatoid arthritis.

Vis M, Bos WH, Wolbink G, Voskuyl AE, Twisk JW, Van de Stadt R, Hamann D, Dijkmans BA, Lems WF.

J Rheumatol. 2008 Mar;35(3):425-8.

PMID: 18322974 [PubMed - indexed for MEDLINE]

Related Articles

Blockade of tumour necrosis factor {alpha} significantly alters the serum level of IgG- and IgA-rheumatoid factor in patients with rheumatoid arthritis.

Yazdani-Biuki B, Stadlmaier E, Mulabecirovic A, Brezinschek R, Tilz G, Demel U, Mueller T, Brickmann K, Graninger WB, Brezinschek HP.

Ann Rheum Dis. 2005 Aug;64(8):1224-6.

PMID: 16014683 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC